SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $144.89 million. The enterprise value is $159.85 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.60 million shares outstanding. The number of shares has increased by 56.11% in one year.
| Current Share Class | 8.60M |
| Shares Outstanding | 8.60M |
| Shares Change (YoY) | +56.11% |
| Shares Change (QoQ) | -2.33% |
| Owned by Insiders (%) | 15.76% |
| Owned by Institutions (%) | 29.57% |
| Float | 5.94M |
Valuation Ratios
The trailing PE ratio is 18.27 and the forward PE ratio is 518.46.
| PE Ratio | 18.27 |
| Forward PE | 518.46 |
| PS Ratio | 3.35 |
| Forward PS | 2.81 |
| PB Ratio | 88.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 37.86 |
| P/OCF Ratio | 25.64 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 27.34, with an EV/FCF ratio of 40.77.
| EV / Earnings | 9.69 |
| EV / Sales | 3.61 |
| EV / EBITDA | 27.34 |
| EV / EBIT | 33.39 |
| EV / FCF | 40.77 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 12.06.
| Current Ratio | 1.31 |
| Quick Ratio | 0.92 |
| Debt / Equity | 12.06 |
| Debt / EBITDA | 3.70 |
| Debt / FCF | 5.65 |
| Interest Coverage | 0.98 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 8.81% |
| Return on Invested Capital (ROIC) | 36.84% |
| Return on Capital Employed (ROCE) | 25.47% |
| Weighted Average Cost of Capital (WACC) | 13.07% |
| Revenue Per Employee | $806,127 |
| Profits Per Employee | $299,855 |
| Employee Count | 55 |
| Asset Turnover | 1.30 |
| Inventory Turnover | 1.82 |
Taxes
In the past 12 months, SANUWAVE Health has paid $86,000 in taxes.
| Income Tax | 86,000 |
| Effective Tax Rate | 0.52% |
Stock Price Statistics
The stock price has decreased by -50.85% in the last 52 weeks. The beta is 1.36, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.36 |
| 52-Week Price Change | -50.85% |
| 50-Day Moving Average | 18.60 |
| 200-Day Moving Average | 28.72 |
| Relative Strength Index (RSI) | 46.46 |
| Average Volume (20 Days) | 118,436 |
Short Selling Information
The latest short interest is 768,285, so 8.93% of the outstanding shares have been sold short.
| Short Interest | 768,285 |
| Short Previous Month | 620,241 |
| Short % of Shares Out | 8.93% |
| Short % of Float | 12.94% |
| Short Ratio (days to cover) | 8.66 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $44.34 million and earned $16.49 million in profits. Earnings per share was $0.92.
| Revenue | 44.34M |
| Gross Profit | 34.03M |
| Operating Income | 4.79M |
| Pretax Income | 16.58M |
| Net Income | 16.49M |
| EBITDA | 5.85M |
| EBIT | 4.79M |
| Earnings Per Share (EPS) | $0.92 |
Full Income StatementBalance Sheet
The company has $10.78 million in cash and $22.16 million in debt, with a net cash position of -$11.39 million or -$1.32 per share.
| Cash & Cash Equivalents | 10.78M |
| Total Debt | 22.16M |
| Net Cash | -11.39M |
| Net Cash Per Share | -$1.32 |
| Equity (Book Value) | 1.84M |
| Book Value Per Share | 0.21 |
| Working Capital | 5.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.79 million and capital expenditures -$1.87 million, giving a free cash flow of $3.92 million.
| Operating Cash Flow | 5.79M |
| Capital Expenditures | -1.87M |
| Depreciation & Amortization | 1.06M |
| Net Borrowing | -7.15M |
| Free Cash Flow | 3.92M |
| FCF Per Share | $0.46 |
Full Cash Flow StatementMargins
Gross margin is 76.74%, with operating and profit margins of 10.80% and 37.20%.
| Gross Margin | 76.74% |
| Operating Margin | 10.80% |
| Pretax Margin | 37.39% |
| Profit Margin | 37.20% |
| EBITDA Margin | 13.19% |
| EBIT Margin | 10.80% |
| FCF Margin | 8.84% |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -56.11% |
| Shareholder Yield | -56.11% |
| Earnings Yield | 11.11% |
| FCF Yield | 2.64% |
Analyst Forecast
The average price target for SANUWAVE Health is $51.00, which is 202.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $51.00 |
| Price Target Difference | 202.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 1:375.
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:375 |
Scores
SANUWAVE Health has an Altman Z-Score of -2.88 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.88 |
| Piotroski F-Score | 5 |
